Protein Tyrosine Phosphatase Nonreceptor Type 2 Exerts Antimetastatic Functions in Pancreatic Ductal Adenocarcinoma

Researchers found protein tyrosine phosphatase nonreceptor type 2 (PTPN2) expression was downregulated in pancreatic ductal adenocarcinoma (PDAC) tissues, and decreased PTPN2 expression was associated with unfavorable prognosis.